TCM
CCCC icon

TCG Crossover Management’s C4 Therapeutics CCCC Stock Holding History

TCG Crossover Management’s Portfolio CCCC Stock Details CCCC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,276,574
Closed -$5.9M – 37
2024
Q2 		$5.9M Hold
1,276,574
– – 0.61% 26
2024
Q1 		$10.4M Hold
1,276,574
– – 0.82% 27
2023
Q4 		$7.21M Hold
1,276,574
– – 0.8% 26
2023
Q3 		$2.37M Hold
1,276,574
– – 0.35% 26
2023
Q2 		$3.51M Buy
1,276,574
+26,574
+2% +$85.4K 0.58% 21
2023
Q1 		$3.92M Buy
+1,250,000
New +$7.36M 0.77% 21

Other funds holding CCCC

LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return